Presentations from the Regenerative Strategies and Emerging Technologies Forum at the American Orthopedic Foot and …

FRANKLIN, Tenn.--(BUSINESS WIRE)--

Numerous presentations were made today during the Regenerative Strategies Forum at the 2012 American Orthopaedic Foot and Ankle Society (AOFAS) annual meeting in San Diego, CA which supported the safety, effectiveness, clinical need, biologic rationale and cost effectiveness of Augment Bone Graft from BioMimetic Therapeutics, Inc. (BMTI).

Regenerative Strategies and Emerging Technologies Pre-meeting Presentations

The forum included lectures by numerous leading foot and ankle surgeons covering regenerative strategies related to foot and ankle surgery. The following presentations highlighted the clinical and pharmaco-economic need and biologic rationale for Augment Bone Graft as an alternative to autograft.

AOFAS Annual Meeting Presentations and Poster

In addition to the above presentations given today at the regenerative forum, the following presentations related to the clinical need for Augment or Augment Injectable Bone Graft will be presented later during the AOFAS annual meeting.

Exhibit Booth

In addition to these surgeon presentations at the AOFAS annual meeting, BioMimetic will host a commercial exhibit booth #401 in the Sapphire Ballroom at the Hilton Bayfront Hotel from June 21 23.

About BioMimetic Therapeutics

BioMimetic Therapeutics (BMTI) is a biotechnology company specializing in the development and commercialization of clinically proven products to promote the healing of musculoskeletal injuries and diseases, including therapies for orthopedics, sports medicine and spine applications. All Augment branded products are based upon recombinant human platelet-derived growth factor (rhPDGF-BB), which is an engineered form of PDGF, one of the body's principal agents to stimulate and direct healing and regeneration. Through the commercialization of this patented technology, BioMimetic seeks to become the leading company in the field of regenerative medicine by providing new treatment options for the repair of bone, cartilage, tendons and ligaments.

More here:
Presentations from the Regenerative Strategies and Emerging Technologies Forum at the American Orthopedic Foot and ...